155 related articles for article (PubMed ID: 18648001)
1. How the c-myc promoter works and why it sometimes does not.
Levens D
J Natl Cancer Inst Monogr; 2008; (39):41-3. PubMed ID: 18648001
[TBL] [Abstract][Full Text] [Related]
2. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.
Liu J; Kouzine F; Nie Z; Chung HJ; Elisha-Feil Z; Weber A; Zhao K; Levens D
EMBO J; 2006 May; 25(10):2119-30. PubMed ID: 16628215
[TBL] [Abstract][Full Text] [Related]
3. Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.
Crichlow GV; Zhou H; Hsiao HH; Frederick KB; Debrosse M; Yang Y; Folta-Stogniew EJ; Chung HJ; Fan C; De la Cruz EM; Levens D; Lolis E; Braddock D
EMBO J; 2008 Jan; 27(1):277-89. PubMed ID: 18059478
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of FIR-mediated c-myc transcriptional control.
Cukier CD; Hollingworth D; Martin SR; Kelly G; Díaz-Moreno I; Ramos A
Nat Struct Mol Biol; 2010 Sep; 17(9):1058-64. PubMed ID: 20711187
[TBL] [Abstract][Full Text] [Related]
5. Quantitative characterization of the interactions among c-myc transcriptional regulators FUSE, FBP, and FIR.
Hsiao HH; Nath A; Lin CY; Folta-Stogniew EJ; Rhoades E; Braddock DT
Biochemistry; 2010 Jun; 49(22):4620-34. PubMed ID: 20420426
[TBL] [Abstract][Full Text] [Related]
6. The FBP interacting repressor targets TFIIH to inhibit activated transcription.
Liu J; He L; Collins I; Ge H; Libutti D; Li J; Egly JM; Levens D
Mol Cell; 2000 Feb; 5(2):331-41. PubMed ID: 10882074
[TBL] [Abstract][Full Text] [Related]
7. c-myc expression: keep the noise down!
Chung HJ; Levens D
Mol Cells; 2005 Oct; 20(2):157-66. PubMed ID: 16267388
[TBL] [Abstract][Full Text] [Related]
8. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
9. The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements.
Albert T; Wells J; Funk JO; Pullner A; Raschke EE; Stelzer G; Meisterernst M; Farnham PJ; Eick D
J Biol Chem; 2001 Jun; 276(23):20482-90. PubMed ID: 11279041
[TBL] [Abstract][Full Text] [Related]
10. Nuclear targeting determinants of the far upstream element binding protein, a c-myc transcription factor.
He L; Weber A; Levens D
Nucleic Acids Res; 2000 Nov; 28(22):4558-65. PubMed ID: 11071946
[TBL] [Abstract][Full Text] [Related]
11. Variable pause positions of RNA polymerase II lie proximal to the c-myc promoter irrespective of transcriptional activity.
Wolf DA; Strobl LJ; Pullner A; Eick D
Nucleic Acids Res; 1995 Sep; 23(17):3373-9. PubMed ID: 7567445
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosis.
Mizokami D; Araki K; Tanaka N; Suzuki H; Tomifuji M; Yamashita T; Ueda Y; Shimada H; Matsushita K; Shiotani A
PLoS One; 2015; 10(1):e0116279. PubMed ID: 25569246
[TBL] [Abstract][Full Text] [Related]
13. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.
Duncan R; Bazar L; Michelotti G; Tomonaga T; Krutzsch H; Avigan M; Levens D
Genes Dev; 1994 Feb; 8(4):465-80. PubMed ID: 8125259
[TBL] [Abstract][Full Text] [Related]
14. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes.
Wahlström T; Belikov S; Arsenian Henriksson M
Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repression from the c-myc P2 promoter by the zinc finger protein ZF87/MAZ.
Izzo MW; Strachan GD; Stubbs MC; Hall DJ
J Biol Chem; 1999 Jul; 274(27):19498-506. PubMed ID: 10383467
[TBL] [Abstract][Full Text] [Related]
16. Making myc.
Liu J; Levens D
Curr Top Microbiol Immunol; 2006; 302():1-32. PubMed ID: 16620023
[TBL] [Abstract][Full Text] [Related]
17. The functional response of upstream DNA to dynamic supercoiling in vivo.
Kouzine F; Sanford S; Elisha-Feil Z; Levens D
Nat Struct Mol Biol; 2008 Feb; 15(2):146-54. PubMed ID: 18193062
[TBL] [Abstract][Full Text] [Related]
18. NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter.
Huth JR; Yu L; Collins I; Mack J; Mendoza R; Isaac B; Braddock DT; Muchmore SW; Comess KM; Fesik SW; Clore GM; Levens D; Hajduk PJ
J Med Chem; 2004 Sep; 47(20):4851-7. PubMed ID: 15369388
[TBL] [Abstract][Full Text] [Related]
19. FBPs are calibrated molecular tools to adjust gene expression.
Chung HJ; Liu J; Dundr M; Nie Z; Sanford S; Levens D
Mol Cell Biol; 2006 Sep; 26(17):6584-97. PubMed ID: 16914741
[TBL] [Abstract][Full Text] [Related]
20. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription.
Hu MC; Rosenblum ND
Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
